Skip to main content

TAK ALG-6.25 (Nesina 6.25 mg)

Generic Name: alogliptin

Pill with imprint TAK ALG-6.25 is Pink, Elliptical/Oval and has been identified as Nesina 6.25 mg. It is supplied by Takeda Pharmaceuticals America, Inc.

Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 6.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-6.25

Nesina 6.25 mg TAK ALG-6.25

Nesina

Generic Name
alogliptin
Imprint
TAK ALG-6.25
Strength
6.25 mg
Color
Pink
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC)
64764-0625
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, ferric oxide red, polyethylene glycol 8000, shellac, ferrosoferric oxide, butyl alcohol, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "TAK ALG-6.25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.